"I believe that we as a company succeeded in supporting our customers with critical solutions during the pandemic, at the same time as we revitalized other parts of the operations where needs have not been as high for some time," says Mattias Perjos, President & CEO of Getinge. "The year was challenging given the global supply chain problems that arose and led to a shortage of components and logistical challenges, but we managed these very well thanks to all of our employees and our successful partnerships with customers, other suppliers and authorities."

Getinge's close collaboration with customers and partners, as well as strategy implementation, has continued to provide value and the company reached its financial targets for 2021. Getinge reported solid underlying growth for all business areas in 2021 and also announced new financial targets for coming years in November.

"We have continued our investments in making health care more efficient and sustainable through increased digitalization," continues Mattias Perjos. "We acquired companies in this area in 2021 and we are continuing to identify potential acquisitions for the future."

Already in the end of 2020, Getinge committed to Scope 1-3 of the Science Based Targets initiative as a next step in achieving the target of becoming a CO₂-neutral company in its own operations by 2025. During 2021, the work has continued according to plan by, for example, transition to renewable sources of energy at some of the company's production sites.

To further reduce the carbon footprint, the entire supply chain is being reviewed and the company is working with suppliers and customers to adopt a circular economy in terms of recycling, managing residual products, logistics and distribution.

"Together with our customers, we are looking at how our products and solutions not only meet basic requirements but can also support them to contribute to a more sustainable world", says Mattias Perjos. "This may involve many areas, such as reducing water consumption and the use of anesthetic gases, but is also about creating a better environment for personnel, patients and their families. Enhanced innovation will be very important in the future and we have created a solid foundation for this."

Getinge publishes its GRI disclosures in a separate report, Getinge Sustainability - ESG Addendum for Annual Report 2021.

The Annual Report and Sustainability Report 2021, as well as the Getinge Sustainability - ESG Addendum for Annual Report 2021 are available at www.getinge.com.  

Media contact:

Lars Mattsson, Head of Investor Relations
Phone: +46 (0) 734 244 692
E-mail: lars.mattsson@getinge.com

This information is information that Getinge is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 4.00 PM CEST on March 30, 2022.

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.